A
$ Value
$0
Shares
1,900
Price
$0
Filed
Apr 17
Insider
Name
Nackel John G.
Title
—
CIK
0001437214
Roles
Director
Transaction Details
Transaction Date
2026-04-15
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
172,665
Footnotes
These shares vest in three annual installments beginning April 15, 2027. | These shares are held by the Nackel Family Trust dated June 30, 1997. Dr. Nackel and his spouse share voting and investment power over the trust.
Filing Info
Nackel John G.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | PNTG | A | $0 |
| 2026-01-15 | PNTG | A | $0 |
| 2025-10-15 | PNTG | A | $0 |
| 2025-07-15 | PNTG | A | $0 |
Other Insiders at PNTG (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| COVEY STEPHEN M R | — | — | 2026-04-15 |
| SMITH BARRY M | — | — | 2026-04-15 |
| Lamb Scott E | — | — | 2026-04-15 |
| Christensen Christopher R. | — | — | 2026-04-15 |
| Snapper Suzanne D. | — | — | 2026-04-15 |
|
Gochnour John J
Chief Operating Officer
|
— | — | 2026-03-05 |
|
Guerisoli Brent
Chief Executive Officer
|
— | — | 2026-03-05 |
| Morris Gregory K Sr. | — | — | 2026-04-15 |
|
Walbom Lynette
Chief Financial Officer
|
— | — | 2026-03-05 |
|
Steik Jason Paul
Chief Clinical Officer
|
— | — | 2026-03-05 |
|
Cheney Kirk Sterling
EVP, GC and Corp Secy
|
— | — | 2026-03-05 |